Autophagy pathway was also enriched in the anti–PD-1–treated group, which supports the increasingly recognized idea that autophagy is a conserved process used by tumor cell to evade immune surveillance and combination of autophagy inhibition with ICT is a promising strategy to overcome resistance to ICT (31–36). The gene discussed is PDCD1; the disease is neoplasm.